The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent cliff for many drug developers.

The conference runs from Monday through Thursday after two years of unprecedented underperformance for the healthcare sector.

The 43rd J.P. Morgan Healthcare Conference in San Francisco will see active participation by Korean pharmaceutical giants and up-and-comers, from featured presentations to deal making.